bioRxivPharmacology & ToxicologyPreprint
Multiple sclerosis: Effects of fixed-dose combination of dimethyl fumarate and NADPH oxidase inhibitor on oxidative stress markers and neurobehavioral activity in mice model of cuprizone-induced demyelination
Abstract
BackgroundMotor coordination (MC) and long-term recognition memory (LRM) are affected in people with multiple sclerosis (MS). The exact mechanism underlying the pathogenesis of MS is still unknown. However, oxidative stress is one of the underlying mechanisms of the pathogenesis of MS that is detrimental to myelin due to an imbalance in the levels of antioxidants. Dimethyl fumarate (DMF) is a first-line treatment for relapsing-remitting multiple sclerosis (RRMS). Since OS plays a significant role in MS, in addition to DMF treatment, inhibition of NADPH oxidases (NOXs) may provide surplus glutathione (GSH) to prevent myelin loss. Hence, the objective of this study was to test the effect of a fixed dose of apocynin (50 mg/kg) combined with a fixed-dose DMF (30 mg/kg) on antioxidants, MC, and LRM in cuprizone (CUP)-induced mice model of demyelination. MethodsThe MC and LRM were evaluated by narrow beam and novel object recognition tests, catalase and superoxide dismutase activity by the degradation of hydrogen peroxide and nitroblue tetrazolium method; malondialdehyde by thiobarbituric acid assay, GSH by high-performance liquid chromatography, and presence of myelin by modified luxol fast blue staining. ResultsThe combination therapy with DMF plus APO in CUP-fed mice preserved LRM and MC with a significant increase in catalase activity (1.15 {+/-} 0.04 U/mg protein; p<0.001), superoxide dismutase activity (9.25 {+/-} 0.10 U/mg protein; p<0.0001), and GSH (195.25 {+/-} 22.75 nmol/mg protein, ****p<0.0001) of the cerebral cortex versus disease control (98.52 {+/-} 8.85 nmol/mg protein). APO plus DMF30 in CUP-fed mice also preserved myelin (p<0.001) at the corpus callosum of mice brains. ConclusionsWe conclude that APO combination with DMF might have protected myelin by modulating (increasing) the levels of antioxidants to act against CUP-induced oxidative stress and thereby preserved MC and LRM in the cuprizone-induced mice model of demyelination.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sub-clinical glutamate receptor antagonist combinations prevent progressive demyelination.
Verity F. T. Mitchener, Chris Bulman, … Robert F. Fern·bioRxiv·Mar 19, 2024
- The role of complex IV activity in the axonal response of mitochondria to demyelination in experimental disease models of multiple sclerosis
Simon Licht‐Mayer, Graham R. Campbell, … Don Mahad·Neuropathology and Applied NeurobiologyPeer-reviewed·Oct 1, 2022
- Microglia are necessary for toxin-mediated demyelination and activation of microglia is sufficient to induce demyelination
Dave E. Marzan, Brian L. West, James L. Salzer·bioRxiv·Dec 19, 2018
- Longitudinal magnetic resonance imaging and spectroscopy in a mouse model of cuprizone-induced demyelination
Esther H. Walters, Davide Di Censo, … Diana Cash·Experimental NeurologyPeer-reviewed·Aug 11, 2026
- Reversible loss of Hippocampal Function in a Mouse Model of Demyelination/Remyelination
Aniruddha Das, Chinthasagar Bastian, … Hod Dana·Frontiers in Cellular NeurosciencePeer-reviewed·Jan 22, 2020
- Remodeling oligodendrocyte lipid metabolism via liver X receptors overcomes inflammatory blockade of remyelination
Judy J. Lee, Matthew D. Smith, … Michael D. Kornberg·bioRxiv·Aug 15, 2026